SIRNAOMICS-B(02257) announced that executive director Pan Honghui has increased his holdings by 38,000 shares.

date
23:15 30/03/2026
avatar
GMT Eight
Sanwa Pharmaceutical-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan had purchased a total of 38,000 ordinary shares of the company on the open market with his personal funds on March 30, 2026, at an average price of approximately 5.93 Hong Kong dollars per share. Following the purchase, Dr. Pan holds a total of 17.6657 million shares, representing 16.10% of the total issued share capital of the company as of the date of this announcement.
SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the executive director and chairman of the company, that he had purchased a total of 38,000 ordinary shares of the company on the open market with his personal funds at an average price of approximately HK$5.93 per share on March 30, 2026. Following the purchase, Dr. Pan now holds a total of 17,665,700 shares, representing 16.10% of the company's total issued share capital as of the date of this announcement. Dr. Pan has expressed confidence in the overall development prospects and potential growth of the group. Subject to applicable laws and regulatory requirements, Dr. Pan does not rule out the possibility of further increasing his shareholding in the company at an appropriate time.